Vincerx Pharma Inc. (VINC)

AI Score

Unlock

0.28

0.02 (9.29%)

At close: Apr 15, 2025, 3:59 PM

0.28

0.00%

After-hours: Apr 15, 2025, 04:00 PM EDT

Vincerx Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net Income	-30.07M	-27.03M	-28.9M	-38.24M	-40.16M	-48.85M	-56.01M	-63.28M	-65.37M	-58.2M	-65.84M	-49.45M	-39.31M	-43.21M	-19M	-16.99M	-10.72M	-384.99K	-77.99K	-44.99K	-40.99K
Depreciation & Amortization	1.09M	1.07M	1.05M	1.02M	915K	898K	880K	863K	939K	1.04M	853K	595K	340K	17K	-31K	-5K	20K	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.47M	3.32M	3.23M	2.71M	3.56M	4.63M	5.59M	8.56M	12.44M	16.8M	20.58M	23.86M	23.31M	21.8M	15.73M	9.1M	4.38M	4.36K	1.36K	357.00	357.00
Other Working Capital	421K	-4.23M	-1.19M	-1.89M	-3.01M	-159K	-2.13M	-3.93M	-2.07M	-1.42M	-523K	2.31M	4.08M	2.43M	1.35M	113K	-1.42M	7.79K	4.79K	2.79K	2.79K
Other Non-Cash Items	932K	3.02M	2.6M	18.39M	11.46M	9.69M	9.92M	-1.74M	-6.59M	-17.65M	-11.06M	-25.22M	-23.36M	-2.16M	-8.61M	6.78M	10.13M	229.84K	72.84K	41.84K	37.84K
Deferred Income Tax	n/a	-1.53M	-1.53M	-12.04M	-12.04M	-10.51M	-10.51M	n/a	n/a	n/a	n/a	n/a	n/a	-4.94M	-4.94M	-4.94M	-4.94M	n/a	n/a	n/a	n/a
Change in Working Capital	-178K	-5.45M	-3.31M	-5.87M	-4.19M	-2.12M	-4.34M	-1.76M	-1.02M	733K	2.77M	5.23M	5.61M	4.44M	3.11M	535K	-959K	198.79K	38.79K	6.79K	2.79K
Operating Cash Flow	-26.13M	-27.96M	-28.23M	-35.1M	-40.45M	-46.25M	-54.48M	-57.67M	-59.6M	-57.27M	-52.7M	-44.99M	-33.4M	-24.05M	-13.89M	-5.72M	-2.28M	-144K	n/a	n/a	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-8K	-30K	-258K	-5.26M	-5.25M	-5.23M	-5M	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5M	n/a	n/a	n/a	-5M	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-11.46M	-11.46M	-9.57M	-7.63M	-11.82M	-34.6M	-53.57M	-47.17M	-42.98M	-20.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	11.68M	10.25M	22.04M	43.24M	53.32M	49.97M	33.68M	12.48M	2.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	5.75K	20.81K	35.62K	41.5K	15.37K	-19.89K	-34.69K	-40.58K	-28.2K	-8K	-5.01M	-10.01M	-10M	-10M	-5M	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	212K	-1.21M	12.47M	35.62M	41.5M	15.37M	-19.89M	-34.69M	-40.58M	-20.2M	-30K	-258K	-5.26M	-5.25M	-5.23M	-5M	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	16.94M	16.93M	17.02M	116K	114K	134K	134K	283K	280K	525K	48.02M	88.45M	88.45M	152.06M	104.74M	64.07M	64.07M	180K	n/a	n/a	n/a
Financial Cash Flow	17.99M	17.02M	17.02M	116K	114K	134K	134K	283K	280K	525K	48.02M	88.45M	88.45M	152.06M	104.74M	64.07M	64.07M	180K	n/a	n/a	n/a
Net Cash Flow	-7.79M	-12.12M	1.26M	633K	1.12M	-30.72M	-74.17M	-91.99M	-99.83M	-76.93M	-4.7M	43.2M	49.77M	122.76M	84.94M	52.67M	61.11M	-648.71K	n/a	n/a	n/a
Free Cash Flow	-26.13M	-27.96M	-28.23M	-35.1M	-40.45M	-46.25M	-54.48M	-57.67M	-59.6M	-57.28M	-52.73M	-45.25M	-38.66M	-29.3M	-19.12M	-10.72M	-2.28M	-144K	n/a	n/a	n/a